SCHEMBL622800

SCHEMBL622800

O=C1NC(=S)S/C1=C/c1ccc(-c2ccccc2F)o1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 10/20 0.80
INSR P06213 3/20 0.74
IGF1R P08069 3/20 0.74
PTP4A3 O75365 1/20 0.69
PIK3CA P42336 3/20 0.58
PIK3CB P42338 1/20 0.58
MAP3K5 Q99683 2/20 0.56
GSK3A P49840 1/20 0.56
GSK3B P49841 1/20 0.56
PIM1 P11309 1/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
RECQL P46063 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622801 1.00 PIK3CG (0.80) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL622799 1.00 PIK3CG (0.80) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL623633 0.86 PIK3CG (0.78) PIK3CGINSRIGF1RPIK3CAPIK3CB
SCHEMBL623632 0.86 PIK3CG (0.78) PIK3CGINSRIGF1RPIK3CAPIK3CB
SCHEMBL623774 0.85 IGF1R (1.00) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL6090652 0.85 IGF1R (0.74) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL623775 0.85 IGF1R (1.00) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL29910211 0.85 IGF1R (0.74) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL6090645 0.85 IGF1R (0.74) PIK3CGINSRIGF1RPTP4A3PIK3CA
SCHEMBL623776 0.85 IGF1R (1.00) PIK3CGINSRIGF1RPTP4A3PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255088-B2 Premature-termination-codons readthrough compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-02-09 US disclosed
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-17 US disclosed
WO-2012021707-A2 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS UPF1, NUDT21, RNGTT PIK3CG 3728/4885INSR 4125/4885IGF1R 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.